Vaginal Progesterone Prophylaxis for Preterm Birth (the OPPTIMUM Study): A Multicentre, Randomized, Double-Blind Trial

Jane Elizabeth Norman, Neil Marlow, Claudia Martina Messow, Andrew Shennan, Phillip R. Bennett, Steven Thornton, Stephen C. Robson, Alex McConnachie, Stavros Petrou, Neil J. Sebire, Tina Lavender, Sonia Whyte, John Norrie

Research output: Contribution to journalComment/debatepeer-review

Abstract

Administration of vaginal progesterone or intramuscular 17α-hydroxyprogesterone caproate has been found to prevent preterm birth in women with a short cervix and to reduce neonatal mortality as reported by the Cochrane Library meta-analysis. However, data on medium and long-term outcomes after the neonatal period are lacking.
Original languageEnglish
Pages (from-to)517-518
Number of pages2
JournalObstetrical & Gynecological Survey
Volume71
Issue number9
DOIs
Publication statusPublished - 1 Sep 2016

Fingerprint Dive into the research topics of 'Vaginal Progesterone Prophylaxis for Preterm Birth (the OPPTIMUM Study): A Multicentre, Randomized, Double-Blind Trial'. Together they form a unique fingerprint.

Cite this